HelloVideos

OncLiveTV

OncLive TV provides short, focused interviews with key oncology thought leaders. This unique platform allows oncology professionals to learn about important developments directly from their peers. Additionally, this channel provides OncLive's Peer Exchange video series, which features peer-to-peer discussions of the clinical and practical challenges cancer care professionals face in today's healthcare environment.

Dr. Pennell on Challenges With NGS in Lung Cancer

Dr. Pennell on Challenges With NGS in Lung Cancer

 
Dr. Sartor on the Significance of the REASSURE Trial in mCRPC

Dr. Sartor on the Significance of the REASSURE Trial in mCRPC

 
Dr. Daver on Updated Findings With Magrolimab/Azacitidine in MDS

Dr. Daver on Updated Findings With Magrolimab/Azacitidine in MDS

 
Managing Symptoms of NF1

Managing Symptoms of NF1

 
Therapeutic Options for NF1 With PNs

Therapeutic Options for NF1 With PNs

 
Dr. Eggermont on Responses to Adjuvant Pembrolizumab in Stage III Melanoma Subtypes

Dr. Eggermont on Responses to Adjuvant Pembrolizumab in Stage III Melanoma Subtypes

 
Dr. Halmos on the Importance of Identifying Biomarkers in Advanced NSCLC

Dr. Halmos on the Importance of Identifying Biomarkers in Advanced NSCLC

 
Dr. Rudin on the Design of the KEYNOTE-604 Trial in ES-SCLC

Dr. Rudin on the Design of the KEYNOTE-604 Trial in ES-SCLC

 
Dr. Weisel on Interim Analysis With Isatuximab Plus KRd in High-Risk Myeloma

Dr. Weisel on Interim Analysis With Isatuximab Plus KRd in High-Risk Myeloma

 
Dr. Leslie on the Benefits With Zanubrutinib in MCL

Dr. Leslie on the Benefits With Zanubrutinib in MCL

 
Dr. Roué on Interest With TG-1701 in Ibrutinib-Resistant MCL Models

Dr. Roué on Interest With TG-1701 in Ibrutinib-Resistant MCL Models

 
Signs and Tests for Diagnosis and Prognosis of HCL

Signs and Tests for Diagnosis and Prognosis of HCL

 
Molecular Genetic Changes for Hairy Cell Leukemia

Molecular Genetic Changes for Hairy Cell Leukemia

 
CORRECT, RECOURSE, and ReDOS Trials in mCRC

CORRECT, RECOURSE, and ReDOS Trials in mCRC

 
Later Lines of Therapy for mCRC

Later Lines of Therapy for mCRC

 
Dr. Ghia on Efficacy and Safety of Acalabrutinib in Relapsed/Refractory CLL

Dr. Ghia on Efficacy and Safety of Acalabrutinib in Relapsed/Refractory CLL

 
. Katz on Redefining Risk Stratification in Prostate Cancer

. Katz on Redefining Risk Stratification in Prostate Cancer

 
Dr. Morris on the Design of the Phase 3 CONDOR Trials in Recurrent Prostate Cancer

Dr. Morris on the Design of the Phase 3 CONDOR Trials in Recurrent Prostate Cancer

 
Dr. Lin on Developing Systemic Therapies for Patients with Brain Metastases in HER2+ Breast Cancer

Dr. Lin on Developing Systemic Therapies for Patients with Brain Metastases in HER2+ Breast Cancer

 
Practical Applications of PRIMA in Ovarian Cancer Management

Practical Applications of PRIMA in Ovarian Cancer Management

 
PRIMA: Frontline Niraparib Maintenance Therapy in Ovarian Cancer

PRIMA: Frontline Niraparib Maintenance Therapy in Ovarian Cancer

 
Exploring CAR T-Cell Therapy During COVID-19: What’s on the Horizon for CAR T-Cell Therapy

Exploring CAR T-Cell Therapy During COVID-19: What’s on the Horizon for CAR T-Cell Therapy

 
Using Molecular Testing in GI Cancers

Using Molecular Testing in GI Cancers

 
Evolution of NGS Testing in Lung Cancers

Evolution of NGS Testing in Lung Cancers

 
CAR T-Cell Therapy in High-Risk Non-Hodgkin Lymphoma

CAR T-Cell Therapy in High-Risk Non-Hodgkin Lymphoma

 
Exploring CAR T-Cell Therapy During the COVID-19 Pandemic: Mitigation and Management of AEs

Exploring CAR T-Cell Therapy During the COVID-19 Pandemic: Mitigation and Management of AEs

 
Understanding the HER2CLIMB Trial

Understanding the HER2CLIMB Trial

 
The Benefits of Tucatinib in HER2+ Breast Cancer

The Benefits of Tucatinib in HER2+ Breast Cancer

 
Treatment for Metastatic Breast Cancer

Treatment for Metastatic Breast Cancer

 
A Close Look at Tucatinib in HER+ Breast Cancer

A Close Look at Tucatinib in HER+ Breast Cancer

 
Conventional Versus PSMA Imaging in Prostate Cancer

Conventional Versus PSMA Imaging in Prostate Cancer

 
PSMA-Targeted Imaging in Prostate Cancer

PSMA-Targeted Imaging in Prostate Cancer

 
Dr. Talati on Rationale for Collecting Real-World Data on Venetoclax/HMA Combos in AML

Dr. Talati on Rationale for Collecting Real-World Data on Venetoclax/HMA Combos in AML

 
Dr. Hope on the Effectiveness of 68Ga-PSMA-11 PET in Prostate Cancer

Dr. Hope on the Effectiveness of 68Ga-PSMA-11 PET in Prostate Cancer

 
Dr. Davids on Updated Data With Ibrutinib/Umbralisib in R/R CLL and MCL

Dr. Davids on Updated Data With Ibrutinib/Umbralisib in R/R CLL and MCL

 
Dr. Shore on the Potential Utility of Relugolix in Advanced Prostate Cancer

Dr. Shore on the Potential Utility of Relugolix in Advanced Prostate Cancer

 
Dr. Gupta on Challenges With Perioperative Immunotherapy in Bladder Cancers

Dr. Gupta on Challenges With Perioperative Immunotherapy in Bladder Cancers

 
Dr. Litton on the EMBRACA Trial in Advanced BRCA1/2+ Breast Cancer

Dr. Litton on the EMBRACA Trial in Advanced BRCA1/2+ Breast Cancer

 
Dr.  Berdeja on Dosing JNJ-4528 in Relapsed/Refractory Multiple Myeloma

Dr. Berdeja on Dosing JNJ-4528 in Relapsed/Refractory Multiple Myeloma

 
Dr. Jonasch on the Safety Profile of MK-6482 in Von Hippel-Lindau Disease–Associated RCC

Dr. Jonasch on the Safety Profile of MK-6482 in Von Hippel-Lindau Disease–Associated RCC

 
Dr. Kopetz on the Rationale for the BEACON CRC Study in BRAF V600E-Mutant mCRC

Dr. Kopetz on the Rationale for the BEACON CRC Study in BRAF V600E-Mutant mCRC

 
Dr. Salani on the Current State of Biomarker Testing in Cervical Cancer

Dr. Salani on the Current State of Biomarker Testing in Cervical Cancer

 
Metastatic Gastric Cancer: Identifying Disease Progression

Metastatic Gastric Cancer: Identifying Disease Progression

 
Switch Maintenance in Gastric Cancer: Results of JAVELIN Gastric 100

Switch Maintenance in Gastric Cancer: Results of JAVELIN Gastric 100

 
Counseling Patients With mCRPC

Counseling Patients With mCRPC

 
CARD Trial In Metastatic CRPC

CARD Trial In Metastatic CRPC

 
Dr. Blank on Adjuvant Versus Neoadjuvant Approaches in Stage III Melanoma

Dr. Blank on Adjuvant Versus Neoadjuvant Approaches in Stage III Melanoma

 
Dr. Shore on Benefits of Immunotherapy INO-5150 in Recurrent Prostate Cancer

Dr. Shore on Benefits of Immunotherapy INO-5150 in Recurrent Prostate Cancer

 
Dr. Bekaii-Saab on Second-Line Treatment Options in HCC

Dr. Bekaii-Saab on Second-Line Treatment Options in HCC

 
Dr. Braunstein on the Utility of Maintenance Therapy in Multiple Myeloma

Dr. Braunstein on the Utility of Maintenance Therapy in Multiple Myeloma

 
Load More Videos
x
This website is using cookies for providing you best experience. More info. That's Fine